One Category Creation Strategy Builds Market-Product Fit in 12 to 18 Months

A category creation strategy is the sequence medtech founders run before hiring sales: category, messaging, narrative, then go-to-market. Skip the first step and every dollar spent on the last one buys less.

I've run this sequence with founders long before they've hired a single rep, and the ones who run it in order get evaluated on their own terms instead of a competitor's.

Key Takeaways

• A category creation strategy runs category, messaging, narrative, then go-to-market, always in that order.
• Market-product fit means the market understands three things: problem, category, approach, before a single sales call happens.
• Minimum viable category is the deliverable that comes out of the first phase, defined before scaling.
• Founders who skip the category phase get commoditized, compared incorrectly, or ignored by the buyers they need.
• The signal that a category creation strategy is working is language adoption: clinicians and buyers use your category's terms unprompted.
• Category is structure: the rules of the evaluation. Branding is the expression built on top of it.

Watch the full episode on YouTube

A Category Creation Strategy Sequences Category, Messaging, Narrative, Then Go-to-Market

A category creation strategy is four disciplines run in a fixed order: category design, messaging, narrative, then go-to-market. Skip ahead and the later work has nothing to stand on.

I covered this on a recent episode about how market engineering helps medtech startups raise capital:

"What will create a market is the sum of category plus messaging plus narrative plus the go-to-market. If any one of those pieces are missing, then none of it's going to work."

Category defines the problem and names it. Messaging carries the positioning and the proof. Narrative is the thought leadership that builds belief before a sales conversation starts.

Go-to-market is last on purpose. It is sales and marketing alignment on top of a category buyers already recognize.

Founders default to hiring reps first because activity feels like progress. But a rep selling into a category that doesn't exist yet in the buyer's head is closing deals nobody else can replicate.

Market-Product Fit Comes Before Product-Market Fit Because the Market Must Understand Category Before Product

Market-product fit means the market already understands three things before your product ever gets pitched: the problem, the category, and your approach to it. Product-market fit assumes a category exists and you're fitting into it.

On the same episode, I laid out the distinction:

"Product market fit is necessary, but it's incomplete. Market product fit means that the market understands three things: problem, category, approach. When they don't know when or why they would use your product, that's the bigger thing."

In medtech, that existing category usually belongs to an incumbent. Compete inside somebody else's category and you inherit their rules, their comparisons, and their evaluation criteria.

A category creation strategy flips the order. Define the category, shape how the market understands the problem, and the product gets evaluated on terms you set.

Minimum Viable Category Anchors the Sequence by Letting Buyers Evaluate You Correctly

Minimum viable category is the concrete output of phase one: enough category definition that buyers, clinicians, and investors evaluate you correctly instead of comparing you to the nearest incumbent.

Founders who've built their first product iteration often resist going back to define this. It feels like a step backward when the FDA clock is already running.

But skipping it doesn't save time. It just moves the cost downstream, into longer sales cycles and messaging that has to work twice as hard because nobody agrees what game is being played.

I've seen this fail the same way across dozens of pitches at accelerators like MedTech Innovator. A founder pitches a strong product with no category to place it in.

Every investor in the room mentally slots it next to whichever comparable company they already know. That's not a good position walking into a fundraising conversation.

Minimum viable category is structure: the rules of the game, the language, the evaluation criteria. Branding is the expression layered on top of that structure once it exists.

The test for whether you've hit minimum viable category is whether clinicians, nurses, and buyers start describing the problem using your category's own language, without your prompting.

That's the earliest real signal a category creation strategy is taking hold, the same test I walked through in what Bruce Cleveland knows about category design.

Language Adoption Signals a Category Creation Strategy Is Working Before Revenue Does

Language adoption is the first proof a category creation strategy is working. Buyers describing the problem in your terms means the category is landing before a single deal has closed.

Early revenue can be episodic. A strong launch and a handful of early adopters prove a founder can sell. They don't prove anyone else in the company can repeat the sale on the same terms.

"Nobody finds you in medtech. You engineer being found."

I said that on an episode about hardball strategy and the psychology of winning, and it captures the change a category creation strategy is built to produce: markets don't form after launch, they're shaped years before it.

Social media and early clinical adopter engagement accelerate this. Every piece of content, every conversation, every pitch deck is a chance to teach the market the language of the category before the market has to be sold on the product itself.

When language adoption shows up before the first big revenue quarter, sales cycles shorten and buyer education costs drop. That's the compounding effect a category creation strategy is designed to produce, and it's the difference between a founder-led sale and a category that starts selling itself.

Category Creation Strategy Determines Whether the Rest of the Go-to-Market Spend Works

In my experience working with medtech founders, category creation strategy gets treated as a nice-to-have once the product and the regulatory pathway are locked, but it's the opposite: the sequencing decision that determines whether the rest of the spend works.

If you're pre-product-iteration, run the category work now, before the product is frozen. If you've already built, go back and do it anyway, the cost of skipping it doesn't disappear, it just shows up later as a longer sales cycle.

I'd tell any founder heading into MedTech Innovator, LSI, or their first institutional raise: bring a category. Investors and strategics need context to place you correctly, and a category gives them that context before they ask for it.

The founders who compound instead of stall treat category, messaging, and narrative as the real go-to-market work. Go-to-market without that foundation is just activity.

Read more on how this sequencing plays out in the medical device marketing strategy disciplines framework and in what traction in business requires before a company can call it real.

Frequently Asked Questions

What is a category creation strategy in medtech?

A category creation strategy is the sequenced discipline of defining a market category, then messaging, then narrative, then go-to-market, in that order. Medtech founders use it to get evaluated on their own terms instead of an incumbent's, before they scale a sales team.

How is category creation different from branding?

Category is structure, the rules, the language, and the evaluation criteria a market uses to judge you. Branding is expression layered on top of that structure. A category creation strategy has to exist before branding has anything to say.

What is minimum viable category?

Minimum viable category is the smallest amount of category definition needed for buyers, clinicians, and investors to evaluate a product correctly instead of comparing it to the nearest incumbent. It's defined before scaling, often before the first sales hire.

How do founders know a category creation strategy is working?

The clearest signal is language adoption: clinicians and buyers start describing the problem using the category's own terms without being prompted. That typically shows up before repeatable revenue does, and it predicts shorter sales cycles once go-to-market starts.

Where to Go From Here

If you're doing this yourself. Start with the 5 pillars of market engineering to see how category creation fits inside the full sequence, and listen to The State of MedTech for the founder interviews this post draws from.

If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. It maps whether your category is defined clearly enough for the rest of the sequence to work before you spend another quarter on go-to-market alone.

Listen to the Full Episode

The full conversation on how market engineering helps medtech startups raise capital is available on The State of MedTech. Watch on YouTube. Subscribe wherever you listen to podcasts.

About the Author

Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, a podcast for medtech founders and commercial leaders.

He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.